Aristolochic acid-induced destruction of organic ion transporters and fatty acid metabolic disorder in the kidney of rats

被引:25
作者
Lou, Yujie [1 ]
Li, Jianmei [1 ]
Lu, Yan [1 ]
Wang, Xing [1 ]
Jiao, Ruiqing [1 ]
Wang, Shuijuan [1 ]
Kong, Lingdong [1 ]
机构
[1] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Peoples R China
关键词
Aristolochic acid; Organic ion transporters; L-carnitine; Lipotoxicity; Nephropathy; ACTIVATED RECEPTOR-ALPHA; BRUSH-BORDER MEMBRANES; ANION TRANSPORTERS; L-CARNITINE; RENAL-FAILURE; DNA-ADDUCTS; NEPHROPATHY; INJURY; MICE; GENE;
D O I
10.1016/j.toxlet.2010.12.007
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Aristolochic acid (AA) nephropathy exhibits early proximal tubular injury and fatty acid metabolic disorder. In order to study the unrecognized abnormalities of organic ion transporters and fatty acid metabolism indicators in AA nephropathy, Wistar rats were orally administrated with vehicle, 10 and 20 mg/kg AA once daily for 7 days, respectively. At day 8, significant reduction of body weight and right kidney weight, as well as elevation of plasma blood urea nitrogen (BUN) levels, renal long-chain fatty acids (LCFAs), non-esterified fatty acids (NEFA) and triglycerides (TG) contents were observed in AA-treated rats, accompanying with down-regulation of renal rOAT1/3, rOCT1/2 and rOCTN1/2 expressions. OCTN2 particularly transports L-carnitine through cell membrane. AA treatment also induced a significant decrease of L-carnitine levels in renal cortex of rats. Down-regulation of peroxisome proliferator-activated receptor alpha (rPPAR alpha) and carnitine acyltransferase 1 (rCPT1), and up-regulation of acetyl coenzyme A carboxylase 1/2 (rACC1/2) in renal cortex were detected in AA-treated rats. These results indicate that alterations of organic ion transportation and fatty acid metabolism are part of AA-induced nephropathy (AAN), contribute to the altered urinary metabolic profile and may lead to further proximal tubule injury in rats. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:72 / 79
页数:8
相关论文
共 52 条
[1]   Renal xenobiotic transporters are differentially expressed in mice following cisplatin treatment [J].
Aleksunes, Lauren M. ;
Augustine, Lisa M. ;
Scheffer, George L. ;
Cherrington, Nathan J. ;
Manautou, Jose E. .
TOXICOLOGY, 2008, 250 (2-3) :82-88
[2]   Sequence-specific detection of aristolochic acid-DNA adducts in the human p53 gene by terminal transferase-dependent PCR [J].
Arlt, VM ;
Schmeiser, HH ;
Pfeifer, GP .
CARCINOGENESIS, 2001, 22 (01) :133-140
[3]   Molecular evidence for an involvement of organic anion transporters (OATs) in aristolochic acid nephropathy [J].
Bakhiya, Nadiya ;
Arlt, Volker M. ;
Bahn, Andrew ;
Burckhardt, Gerhard ;
Phillips, David H. ;
Glatt, Hansruedi .
TOXICOLOGY, 2009, 264 (1-2) :74-79
[4]   A HIGH-YIELD PREPARATION FOR RAT-KIDNEY BRUSH-BORDER MEMBRANES - DIFFERENT BEHAVIOR OF LYSOSOMAL MARKERS [J].
BIBER, J ;
STIEGER, B ;
HAASE, W ;
MURER, H .
BIOCHIMICA ET BIOPHYSICA ACTA, 1981, 647 (02) :169-176
[5]   A MILD, RAPID, AND EFFICIENT METHOD OF LIPID EXTRACTION FOR USE IN DETERMINING VITAMIN-E LIPID RATIOS [J].
BURTON, GW ;
WEBB, A ;
INGOLD, KU .
LIPIDS, 1985, 20 (01) :29-39
[6]   Aristolochic acid induced changes in the metabolic profile of rat urine [J].
Chan, Wan ;
Cai, Zongwei .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2008, 46 (04) :757-762
[7]   A sensitivity enhanced high-performance liquid chromatography fluorescence method for the detection of nephrotoxic and carcinogenic aristolochic acid in herbal medicines [J].
Chan, Wan ;
Lee, Kim-Chung ;
Liu, Ning ;
Cai, Zongwei .
JOURNAL OF CHROMATOGRAPHY A, 2007, 1164 (1-2) :113-119
[8]  
*CHIN PHARM COMM, 2000, PHARM PEOPL REP CHIN, P39
[9]   Protein tyrosine phosphatase 1B: A potential leptin resistance factor of obesity [J].
Cook, WS ;
Unger, RH .
DEVELOPMENTAL CELL, 2002, 2 (04) :385-387
[10]   Renal clearance of endogenous hippurate correlates with expression levels of renal organic anion transporters in uremic rats [J].
Deguchi, T ;
Takemoto, M ;
Uehara, N ;
Lindup, WE ;
Suenaga, A ;
Otagiri, M .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 314 (02) :932-938